MedTrace Logo

Avecure Flexible Microwave Ablation Probe For Lung Nodules

NCT05281237 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-04-08

No results posted yet for this study

Summary

This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size.

This research study involves microwave ablation (MWA)

Conditions

  • Stage I - II Primary Lung Cancer
  • Stage I Lung Cancer
  • Stage II Lung Cancer
  • Lung Cancer Stage I
  • Lung Cancer Stage II
  • Lung Cancer

Interventions

DEVICE

AveCure 16 Gauge Flexible Microwave Ablation Probe

Microwave ablation of the solitary pulmonary nodule will be performed through a bronchoscopic approach using the AveCure Flexible Microwave Ablation Probe before surgery

Sponsors & Collaborators

Principal Investigators

  • Jason Beattie, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2026-12-30
Completion
2027-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05281237 on ClinicalTrials.gov